Walder Wyss advised Kanalservice Group, a portfolio company of Ufenau Capital Partners, on its acquisition of Roberit, Labosim Markierungs and Klose-Vital as part of the group’s ongoing growth strategy. Kanalservice Group is a full-service provider in the field of underground infrastructure maintenance and road markings, with 46 subsidiaries and over 1,200 specialists in Switzerland, Germany, […]
Bär & Karrer advised Netrics Group, a portfolio company of funds advised by Bregal Unternehmerkapital, on Garaio’s majority stake acquisition, Kellerhals Carrard advised Garaio’s shareholders on the transaction. Garaio is a swiss
Vischer advised BID Equity on Realview’s acquisition, a developer and software distributor for the Swiss construction industry. Founded in 2013 and based in Zurich, Realview, with it stried-and-tested software solutions, operates a decisive contribution to
Bratschi advised the shareholders of Mental Capital, an asset manager based in Lucerne, on its acquisition by Colombo Wealth. The team M&A partner Etienne Gard (pictured left) and tax partner Michael Barrot (pictured
Wenger Vieli advised Alturos Destinations, a provider of tourism technology solutions, on all Swiss legal and tax matters during the sale to Juniper Group. The funds will support Alturos’ growth and expand its international market
On 23 May 2024, Houzy AG announced that Houzy and Devis.ch SA are merging. Walder Wyss advised Houzy Corporate/M&A with a team led by managing associates Dario Galli (pictured left) and Michael Kü
by claudia la via In 2024, the Swiss M&A landscape is predicted to see a robust recovery, marking a stark contrast from the cautious approach witnessed in 2023. As companies align with more stable economic
Kontivia Beteiligungen, a Zurich based long term oriented investment firm advised by Kellerhals Carrard, led a group of swiss entrepreneurial families, advised by Baker McKenzie, in the acquisition of a majority stake in Walter Meier (
Homburger advised Biopas on its sale to Swixx Biopharma, a swiss-based global commercial platform focusing on guaranteeing access to innovative medicines worldwide. The founders of Biopas will become shareholders of Swixx Biopharma. The transaction is
Baker McKenzie advised Arbonia on a EUR 100 million bridge loan facility regarding its acquisition of Dimoldura Group and Lignis. The facility was erogated by UBS Switzerland, which was advised by Niederer Kraft Frey (NKF).
